Home/Filings/4/0001596783-19-000048
4//SEC Filing

BUZY PETER L 4

Accession 0001596783-19-000048

CIK 0001596783other

Filed

May 20, 8:00 PM ET

Accepted

May 21, 5:40 PM ET

Size

10.8 KB

Accession

0001596783-19-000048

Insider Transaction Report

Form 4
Period: 2019-05-17
BUZY PETER L
President, Gene Therapy
Transactions
  • Award

    Options to purchase Common Stock

    2019-05-17+230,093230,093 total
    Exercise: $0.88From: 2019-05-17Exp: 2024-12-16Common Stock (230,093 underlying)
  • Award

    Restricted Stock Units

    2019-05-17+44,08244,082 total
    Exercise: $0.00From: 2021-05-17Exp: 2021-05-17Common Stock (44,082 underlying)
  • Award

    Options to purchase Common Stock

    2019-05-17+161,813161,813 total
    Exercise: $45.37From: 2021-05-17Exp: 2029-05-17Common Stock (161,813 underlying)
Footnotes (5)
  • [F1]Options to purchase common stock received by the reporting person under the Issuer's omnibus incentive plan in connection with the assumption of certain vested, in-the-money options held by reporting person under the incentive plan of Paragon Bioservices, Inc. coincident with that entity's acquisition by one of Issuer's subsidiaries. The number of options and the exercise price thereof are subject to adjustment based on post-closing net purchase price adjustments.
  • [F2]Options to purchase common stock received by the reporting person under the Issuer's omnibus incentive plan in connection with reporting person's election as an executive officer of Issuer.
  • [F3]Vesting as to 50% of the options may be accelerated based on the satisfaction of certain performance criteria.
  • [F4]Restricted stock units (RSUs) received by the reporting person under the Issuer's omnibus incentive plan in connection with reporting person's election as an executive officer of Issuer. Each RSU represents the right to receive one share of the Issuer's common stock as of the date of vesting.
  • [F5]Vesting will not occur, and the RSUs will be forfeited, if reporting person fails to purchase and hold an agreed-upon amount of the Issuer's common stock through the scheduled vesting date.

Issuer

Catalent, Inc.

CIK 0001596783

Entity typeother

Related Parties

1
  • filerCIK 0001252570

Filing Metadata

Form type
4
Filed
May 20, 8:00 PM ET
Accepted
May 21, 5:40 PM ET
Size
10.8 KB